Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Tax Payment
Ordinary Shares
2024-03-05$117.53/sh−4,294$504,674→ 62,226 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.